BioVolutions is a Contract Research Organization CRO servicing clients whose interests range from cell development to clinical trial manufacturing. BioVolutions' mission is to save time and minimize costs required to obtain tox supplies and clinical trial material.
Maurizio Cattaneo, PhD founded BioVolutions to offer services originating from his many years of expertise in formulation development, drug delivery and analytical development. Dr. Cattaneo obtained his PhD at McGill University under the direction of Dr. Thomas W Chang, the pioneer of microencapsulation for medical applications. Dr. Cattaneo contribution to bioanalytical development centered on the development of new analytical assays based on amperometry and chemiluminescence.